Skip to main content
SpringerLink
Log in

The iron component of sodium nitroprusside blocks NMDA-induced glutamate accumulation and intracellular Ca2+ elevation

  • Original Articles
  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

These studies were designed to compare the effects of nitric oxide (NO) generating compounds with those of several iron containing, compounds which do not generate NO on glutamate receptor function. Stimulation of primary cultures of cerebellar granule cells with N-methyl-D-aspartate (NMDA) or kainate results in the elevation of intracellular calcium ([Ca2+]i) and cGMP and the release of glutamate. The iron containing compounds, sodium nitroprusside (SNP), potassium ferrocyanide (K4Fe(CN)6) and potassium ferricyanide (K3Fe(CN)6) decrease the NMDA-induced release of glutamate. SNP is the only compound of the above 3 agents which generates NO. A non-iron, NO generating compound, S-nitroso-N-acetylpenicillamin (SNAP), has no effect on the NMDA-induced glutamate release. Potassium ferrocyanide (Fe II), but not potassium ferricyanide (Fe III), blocks NMDA-induced cGMP elevations after 3 min exposure times. This contrasts with the NO generating compounds (both SNP and SNAP) which elevate cGMP levels. Furthermore, both potassium ferrocyanide (Fe II) and SNP (Fe II) suppress the elevation of [Ca2+]i induced by NMDA but neither potassium ferricyanide (Fe III) nor SNAP are effective in this regard. These effects are also independent of cyanide as another Fe II compound, ferrous sulfate (FeSO4) is also able to suppress NMDA-induced elevations of [Ca2+]i SNP was unable to suppress kainate receptor functions. Collectively, these results indicate that Fe II, independently of NO, has effects on NMDA receptor function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bliss, T. V., and Collingridge, G. L. 1993. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361:31–39.

    PubMed  Google Scholar 

  2. Bourne, H. R., and Nicoll, R. 1993. Molecular machines integrate coincident synaptic signals, Cell/Neuron 72/10 (supple):65–75.

    Google Scholar 

  3. Monaghan, D. T., and Cotman, C. W. 1985. Distribution of NMDA-sensitive L-3H-glutamate binding sites in rat brain as determined by quantitative autography. J. Neurosci. 5:2909–2919.

    PubMed  Google Scholar 

  4. Johnson, J. W., and Ascher, P. 1987. Glycine potentiates the NMDA response in cultured mouse brain neurons, Nature 325:529–575.

    PubMed  Google Scholar 

  5. Anis, N. A., Berry, S. C., Burton, N. R., and Lodge, D. 1983. The dissociative anaesthetics ketamins and phencyclidine, selectively reduce excitation of central mammalian neurons by N-methyl-aspartate. Br. J. Pharmacol. 79, 565.

    PubMed  Google Scholar 

  6. Huettner, J. E., and Bean, B. P. 1988. Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: Selective binding to open channels, Proc. Natl. Acad. Sci. 85:1307–1311.

    PubMed  Google Scholar 

  7. Nowak, L., Bregestovski, P., Ascher, P., Herbet, A., and Prochiantz, A. 1984. Magnesium gates glutamate-activated channels in mouse central neurons, Nature 307:462–465.

    PubMed  Google Scholar 

  8. Mayer, M. L., Westbrook, G. L., and Guthrie, P. B. 1984. Voltagedependent block by Mg++ of NMDA responses in spinal cord neurons, Nature 309:261–263.

    PubMed  Google Scholar 

  9. Peters, S., Koh, J., and Choi, D. W. 1987. Zinc selectively blocks the action of N-methyl-D-aspartate on cortical neurons, Science 236:589–592.

    PubMed  Google Scholar 

  10. Westbrook, G. L., and Mayer, M. L. 1987. Micromolecular concentrations of Zn++ antagonize NMDA and GABA responses of hippocampal neurons, Nature 328:640–643.

    PubMed  Google Scholar 

  11. Aizenman, E., Lipton, S. A., and Loring, R. H. 1989. Selective modulation of NMDA responses by reduction and oxidation, Neuron 2:1257–1263.

    PubMed  Google Scholar 

  12. Kohr, G., Eckardt, S., Luddens, H., Monyer, H., and Seeberg, P. H. 1994. NMDA receptor channels: subunit-specific potentiation by reducing agents, Neuron 2:1031–1040.

    Google Scholar 

  13. Manzoni, O., Prezeau, L., Marin, P., Deshager, S., Bockaert, J., and Fagni, L. 1992. Nitric oxide-induced blockade of NMDA receptors, Neuron 8:653–662.

    PubMed  Google Scholar 

  14. Ujihara, H., Akaike, A., Tamura, Y., Yokota, T., Sasa, M., Kashii, S., and Honda, Y. 1993. Blockade of retinal NMDA receptors by sodium nitroprusside is probably due to nitric oxide formation, Japan J. Pharmacol. 61:375–377.

    Google Scholar 

  15. Bredt, D. S., and Snyder, S. H. 1989. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum, Proc. Natl Acad. Sci. 86:9030–9033.

    PubMed  Google Scholar 

  16. Garthwaite, J., Charles, S. L., and Chess-Williams, R. 1988. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain, Nature 336:385–388.

    PubMed  Google Scholar 

  17. McCaslin, P. P., and Morgan, W. W. 1987. Cultured cerebellar cells as anin vitro model of excitatory amino acid receptor function, Brain Res. 417:380–384.

    PubMed  Google Scholar 

  18. Ellison, D. W., Beal, M. F., and Martin, J. B. 1987. Amino acid neurotransmitters in postmortem human brain analyzed by high performance liquid chromatography with electrochemical detection, J. Neurosci. Metho., 19:305–315.

    Google Scholar 

  19. Bradford, M. M. 1976. A rapid sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analyt. Biochem., 72:248–254.

    PubMed  Google Scholar 

  20. Cai, Z., and McCaslin, P. P. 1992. Amitriptyline, desipramine, cyproheptadine and carbamazepine, in concentrations used therapeutically, reduce kainate- and N-methyl-D-aspartate-induced intracellular Ca2+ levels in neuronal culture, Eur. J. Pharmacol. 219:53–57.

    PubMed  Google Scholar 

  21. Grynkiewicz, G., Poenie, M. F., and Tsien, R. Y. 1985. A new generation of Ca2+ indicators with greatly improved fluorescence properties, J. Biol. Chem. 260:3440–3450.

    PubMed  Google Scholar 

  22. Lonart, G., Wang J. W., and Johnson, K. M. 1992. Nitric oxide induces neurotransmitter release from hippocampal slices, Eur. J. Pharmacol. 220:271–272.

    PubMed  Google Scholar 

  23. Lawrence, A. J., and Jarrot, B. 1993. Nitric oxide increases interstitial excitatory amino acid release in the rat dorsomedial medulla oblongata, Neurosci, Lett. 151:126–129.

    Google Scholar 

  24. Hoyt, K. R., Tang, L. H., Aizenman, E., and Reynolds, I. 1992. Nitric oxide modulates NMDA-induced increases in intracellular Ca2+ in cultured rat forebrain neurons, Brain Res. 592:310–316.

    PubMed  Google Scholar 

  25. Lei, S. Z., Pan, Z. H., Aggarwal, S. K., Chen, H. V., Hartman, J., Sucher, N. J., and Lipton, S. A. 1992. Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex, Neuron 8:1087–1099.

    PubMed  Google Scholar 

  26. Wroblewski, J. T., Kledrowski, L., Raulli, R., and Costa, E. 1992. Role of nitric oxide in signal transduction of glutamate receptors. in. Excitatory amino acids, ed. R. P. Simon, (Thieme Medical Publishers, New York) p. 81–87.

    Google Scholar 

  27. Southam, E., and Garthwaite, J. 1991. Comparative effects of some nitric oxide donors on cyclic GMP levels in rat cerebellar slices, Neurosci. Lett. 130:107–109.

    PubMed  Google Scholar 

  28. Lipton, S. A. 1993. Prospects for clinically tolerated NMDA antagonists: Open-channel blockers and alternative redox states of nitric oxide, TINS 16:527–532.

    PubMed  Google Scholar 

  29. Lipton, S. A., Choi, Y. B., Pan, Z. H., Lei, S. Z., Chen, H. V., Sucher, N. J., Loscalzo, J., Singel, D. J., and Stamler, J. S. 1993. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds, Nature 364:626–632.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology and Toxicology, University of Mississippi Medical Center, 39216-4045, Jackson, Mississippi

    Seikwan Oh

  2. Division of Research, Ochsner Medical Foundation, 1516 Jefferson Highway, 70121, New Orleans, Louisiana

    Patrick P. McCaslin

Authors
  1. Seikwan Oh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Patrick P. McCaslin
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oh, S., McCaslin, P.P. The iron component of sodium nitroprusside blocks NMDA-induced glutamate accumulation and intracellular Ca2+ elevation. Neurochem Res 20, 779–784 (1995). https://doi.org/10.1007/BF00969689

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00969689

Key Words

Search

Navigation